Anebulo Pharmaceuticals News

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.

16:18 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cunningham, Richard Anthony

Dec 10 09:04 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason

Jun 17 16:27 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHAH BIMAL R.

Jun 17 16:27 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.

Jun 17 16:27 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lawler Joseph F.

Jun 17 16:26 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kupchyk Areta

Jun 17 16:26 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Calloway Nathaniel

Jun 17 16:26 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Kenneth

Jun 17 16:26 ET

Anebulo Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Cundy Kenneth C

Mar 8 08:10 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cundy Kenneth C

Mar 1 18:25 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.

Dec 20, 2023 16:22 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Cunningham, Richard Anthony

Oct 11, 2023 17:25 ET

Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Cunningham, Richard Anthony

Oct 11, 2023 17:23 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHAH BIMAL R.

Oct 10, 2023 21:49 ET

Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director SHAH BIMAL R.

Oct 10, 2023 21:46 ET

Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer George Dan

Oct 2, 2023 17:01 ET

Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer GARDINER SANDRA A.

Apr 4, 2023 18:32 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Dec 13, 2022 21:19 ET

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Dec 13, 2022 21:18 ET